Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 2,001-2,022 of 2,022
RecruitingNCT04005378

Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
CompletedNCT05314153

Effects Zulresso on Postpartum Psychosis

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
CompletedNCT02969369

A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 55 Years to 105 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
CompletedNCT06450184

Bioequivalence Study of Pimavanserin 34 mg Capsule

This study exists to explore whether the medication Pimavanserin could improve care and understanding. Researchers are trying to understand what the medication Pimavanserin could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
India
Sponsor
Humanis Saglık Anonim Sirketi
Condition
Schizophrenia
CompletedNCT04199468

THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis

This study exists to better understand the safety of brain scans or other body measurements and how manageable it feels in practice. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
RecruitingNCT06314204

Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Centre hospitalier de Ville-Evrard, France
Condition
Schizophrenia
RecruitingNCT05827900

Metacognitive Training in Ultra-high Risk

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 40 Years
Countries
Austria
Sponsor
Medical University of Vienna
Condition
Schizophrenia
TerminatedNCT02357849

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
RecruitingNCT03932136

Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 45 Years
Countries
China
Sponsor
Shanghai Jiao Tong University School of Medicine
Condition
Schizophrenia
CompletedNCT05737966

Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist

This study exists to understand what helps questionnaires and follow-up reports work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether questionnaires and follow-up reports can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Condition
Schizophrenia
CompletedNCT04694482

The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology

This study exists to compare options and see whether the medication COVID-19 offers something meaningfully different. Researchers are trying to understand whether the medication COVID-19 can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Italy
Sponsor
University of Milano Bicocca
Condition
Schizophrenia
CompletedNCT01399437

Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia

This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Schizophrenia
Not Yet RecruitingISRCTN18662002

Identifying and validating cognitive profiles in schizophrenia and bipolarity

This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

BipolarityOtherFrom 18 Years to 100 Years
Countries
Spain
Sponsor
Centro de Investigación Biomédica en Red de Salud Mental
Condition
Bipolarity
Not Yet RecruitingISRCTN13022511

Identifying and validating cognitive profiles in schizophrenia and bipolarity: prospective phase of the PerfilesMICEmiEZ-TB study

This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

BipolarityOtherFrom 18 Years to 100 Years
Countries
Spain
Sponsor
Centro de Investigación Biomédica en Red de Salud Mental
Condition
Bipolarity
RecruitingISRCTN18014168

Evaluation of NBI-1117570 in adults with stable schizophrenia

This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Neurocrine Biosciences (United States)
Condition
Schizophrenia
TerminatedISRCTN12436326

Effectiveness of the creative space for mental health program in improving the quality of life of users of psychiatric services

This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

SchizophreniaOtherOver 18 Years
Countries
Serbia
Sponsor
Psychosocial Innovation Network
Condition
Schizophrenia
TerminatedISRCTN20829222

How does the regular standardized assessment of antipsychotic-induced side effects in forensic psychiatric patients affect the management of these side effects?

This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Department of Health (UK)
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research